SOAT1 and acute myeloid leukemia: Previous studies have shown that ritanserin downregulates key signaling molecules, including sphingosine kinase 1, JAK–STAT, MAPK, PARP, caspase-3, MCL1, and Bcl-xL in Kasumi-1 and KG-1α (AML) cell lines [13].